Gipson, Debbie S <br/><br/>
Clinical trials treating focal segmental glomerulosclerosis should measure patient quality of life.  [electronic resource] 

 -  Kidney international  Mar 2011 
 - 678-685 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1523-1755 
<br/><br/><label>Standard No.: </label>10.1038/ki.2010.485  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adolescent<br/>Adult<br/>Chi-Square Distribution<br/>Child<br/>Child, Preschool<br/>Dexamethasone--administration & dosage<br/>Drug Resistance<br/>Drug Therapy, Combination<br/>Female<br/>Glomerular Filtration Rate<br/>Glomerulosclerosis, Focal Segmental--complications<br/>Humans<br/>Immunosuppressive Agents--administration & dosage<br/>Male<br/>Mycophenolic Acid--administration & dosage<br/>Prospective Studies<br/>Proteinuria--drug therapy<br/>Pulse Therapy, Drug<br/>Quality of Life<br/>Regression Analysis<br/>Research Design<br/>Surveys and Questionnaires<br/>Time Factors<br/>Treatment Outcome<br/>United States<br/>Young Adult